HCW Biologics Inc. — Director's Dealing 2021

Jul 19, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HCW Biologics Inc. (HCWB)
CIK: 0001828673
Period of Report: 2021-07-19

Reporting Person: Medmira Capital Ltd. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Redeemable Preferred Stock	$		Common Stock (2857142)		Direct
Series C Redeemable Preferred Stock	$		Common Stock (730519)		Direct

Footnotes

F1: The Series B Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.

F2: The Series C Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.